ArticleClinical and experimental immunology2020

STIM1 knock-down decreases the affinity of obinutuzumab for CD20 by altering CD20 localization to Triton-soluble membrane.

W Heo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.